ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

TRX Tissue Regenix Group Plc

61.50
0.00 (0.00%)
Last Updated: 08:00:13
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Tissue Regenix Group Plc LSE:TRX London Ordinary Share GB00BNTXR104 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 61.50 61.00 62.00 61.50 61.50 61.50 186 08:00:13
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 29.49M -302k -0.0043 -143.02 43.4M
Tissue Regenix Group Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker TRX. The last closing price for Tissue Regenix was 61.50p. Over the last year, Tissue Regenix shares have traded in a share price range of 49.00p to 71.50p.

Tissue Regenix currently has 70,574,468 shares in issue. The market capitalisation of Tissue Regenix is £43.40 million. Tissue Regenix has a price to earnings ratio (PE ratio) of -143.02.

Tissue Regenix Share Discussion Threads

Showing 13826 to 13849 of 14750 messages
Chat Pages: Latest  554  553  552  551  550  549  548  547  546  545  544  543  Older
DateSubjectAuthorDiscuss
13/10/2021
16:13
Good sign yes, in decent volume too. They see the big picture though and their investment horizon is in years. The average investor/trader looks for quick wins, so I suspect the price will drift to the technical level of 0.3-0.4 before moving any higher.
alancapone
13/10/2021
16:09
directors have been buying recently - that's a good sign?
johneee
11/10/2021
11:11
Something must be up ........as there's plenty of buyers interest today
johneee
08/10/2021
15:20
TRX are in a great market place with super Products and Services. With demand increasing every day its a prime opportunity to be bought out at these prices with a potential target price about 4-5p or more. News may flow this month so dont miss out as TRX is a rare prospect. Future is very bright for this turnaround QTR..
rocketblast
08/10/2021
14:29
II's sell for many different reasons. There is many many examples of II's on AIM selling at any price when they decide to exit, often completely uncorrelated to a companies prospects. In fact a large II selling down can often lead to good buying opportunities as they can cause a technical depression in the share price In this instance the shares seem to have gone to a solid holder so all good.
ryesloan
08/10/2021
12:51
Hi rocketblast, logic would be that an II would know more about what's going on than a pi, so based on your post, what I can't get my head around is why would a II sell over 300M this week if there was a very lucrative "pot of gold" just around the corner.

Again, based on some of your previous posts, then some of them do 'happen', so I wouldn't like to put a bet on against them !!

channel pirate
08/10/2021
12:45
@rocketblast do you have either a crystal ball or perhaps insider info?
ultrasilva
08/10/2021
12:10
CliffPeat, great update, ducks are now getting aligned so takeover more likely. Will happen much sooner than we think. TRX will have to release RNS soon.
rocketblast
08/10/2021
11:29
Oryx International Growth Fund Limited (OIG) now holds 10.66% of TRX

OIG is based in Gibraltar and listed in London

Ultimate controlling person of OIG is Christopher Mills (CM).

CM "is currently Chairman of EKF Diagnostics and Renalytix AI." Both are listed companies in London and in Med-Tech. So he definitely has insight into the market place.


It seems that CM's confidence in the prospects of TRX has increased and now together with IP Group (IPO) they own about 20% of TRX

(Significant shareholders not updated on TRX web site since 17May21

Feeling positive - but as ever DYOR

cliffpeat
08/10/2021
09:29
Agree, we are looking at a new phase for TRX. Top up if you can and be patient expect breakthrough soon and future bright.
rocketblast
08/10/2021
08:41
Fighting to buy on news of large orders piling in due to pent up demand caused by CovidDirector just bought 9 million sharesSomething brewing here
tnt99
08/10/2021
08:35
TRX having a great start to Q4. Orders shooting up and seeing a 0.7 breakout soon with 1.2p target. With likely takeover some say 4-5p plus value . Now its How High How Soon so be patient as this is the QTR. Massive opportunity to top up at these great value prices.
rocketblast
08/10/2021
07:57
Here we go up up and away
tnt99
08/10/2021
07:17
WowMay consider thisHTTPS://www.twitter.com/DVH_Phoenix/status/1446358852170096640
whocares765
06/10/2021
14:35
TRX the big question is who did BUY FROM IP Group. Takeover more likely and soon. Top up and get ready like me.
rocketblast
05/10/2021
17:03
So the TR1 duly appeared. The IP Group are the sellers with their holding down by about a third to 9.29%.
gsg
05/10/2021
11:48
rocketblast. If it were a US based company looking at TRX, the prime candidate would be Arthrex imo.
gsg
05/10/2021
11:01
I am just hoping this support holds.
guy gibson
05/10/2021
10:59
TRX holders be Patient as i expect a buyer in the pipeline so get ready with a 2p plus offer. TRX are in a great space and value at these levels and the pound is low. I suspect US takeover soon.
rocketblast
05/10/2021
09:30
300m trade just printed. Will be interesting to see the identity of the buyer/seller, if a TR1 is issued.
gsg
04/10/2021
22:39
Posted by AquaeSulis01 on the Smith and Nephew thread. Hopefully could potentially have a similar beneficial effect to TRX business prospects.


"re covid uncertainty, the number of red list travel destinations are due to be slashed because Covid-19 hospitalisation rates have confounded modelling which suggested that daily admissions could number 7,000 this month, when in fact they appear to have plateaued at 600. This reduced burden on the NHS, coupled with the 1 in 5 patients on the NHS routine operation waiting list going private, should start to reflect in improved figures for S&N as early as the Nov 4th update. As for the fly season."

gsg
04/10/2021
12:45
@CliffPeat

Thanks for that. As a wholly owned subsidiary TRX Orthopaedics Ltd results are consolidated into the statutory accounts of Tissue Regenix Group PLC. Likely to do with legacy group structure and kept alive to preserve CT losses. Turnover apportioned to the subsid is not relevant for tax or accounting(both are UK based).

Osteotec are a distributor.

b1inkers
04/10/2021
12:13
I continue to be long term bullish on TRX, but....

If 0.6 support goes the next support zone is .36 to .0.4.

david gruen
03/10/2021
12:56
Apparently Tissue Regenix have combined tax losses of over £70m. Set against future profits, that will be a big positive.

Tissue Regenix is a product company which is a brand. What's your point?

gsg
Chat Pages: Latest  554  553  552  551  550  549  548  547  546  545  544  543  Older

Your Recent History

Delayed Upgrade Clock